Navigation Links
Targeted radiation therapy minimizes GI side effects for prostate cancer patients, Penn study shows
Date:10/26/2010

SAN DIEGO -- Prostate cancer patients who receive intensity modulated radiation therapy (IMRT) are less apt to suffer serious gastrointestinal complications following their treatment than those who receive three-dimensional conformal radiotherapy (CRT), according to new research from the University of Pennsylvania School of Medicine. The study, which will be presented Nov. 1 at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO) in San Diego, found that men who were treated with IMRT had fewer serious bowel complications, including painful rectal inflammation and bleeding (3.5 percent), compared to those who received CRT (4.5 percent).

"While radiotherapy is highly effective in treating prostate cancer, men may live with gastrointestinal, urinary and sexual side effects of treatment for many years. Minimizing these side effects and improving men's quality of life after prostate cancer treatment is incredibly important," says Justin Bekelman, MD, lead author of the study and an assistant professor of Radiation Oncology at the University of Pennsylvania School of Medicine. "Our study offers important evidence to patients and their doctors that IMRT is associated with fewer gastrointestinal problems after treatment."

CRT, the conventional form of radiation therapy, uses imaging studies including CT, MRI and PET scans to map the size, shape and location of tumors and the other organs in the area. IMRT is a more advanced version of CRT, offering a more targeted dose of radiation to the cancerous prostate gland. Since both forms of radiation pass all the way through the body after attacking their target, healthy tissue in the rectum and bladder may be damaged by the radiation beam, causing side effects during and after treatment. Though Medicare and private insurers typically cover both IMRT and CRT, little research has been conducted to show which treatment is associated with less side effects an important consideration for men choosing among the various treatment options for the disease, which include observation, radiation, surgery, chemotherapy and hormonal therapies.

Using a Medicare database of men across the United States, Bekelman's team studied 12,598 men 65 years and older who were diagnosed with non-metastatic prostate cancer between 2002 and 2004. The authors followed the patients through 2006 and identified complications that were serious enough to require invasive procedures (including surgeries) and/or hospitalization. The findings revealed that among men who received IMRT, 18.8 percent had serious bowel complications during the two years after their treatment, compared to 22.5 percent of men treated with CRT. (Since specifics about each patient's case could not be accounted for in the database, the authors note that some of the complications identified may have been caused by factors other than radiation treatment.) The researchers found no substantial difference in incidence of urinary or sexual side effects such as erectile dysfunction, but Bekelman notes that since the study was limited to complications involving invasive surgical procedures, it may not capture the true prevalence of sexual side effects following treatment, for which patients may have sought less invasive remedies.


'/>"/>

Contact: Holly Auer
holly.auer@uphs.upenn.edu
215-349-5659
University of Pennsylvania School of Medicine
Source:Eurekalert

Related medicine news :

1. Targeted delivery of losartan reduces liver inflammation and scarring
2. Gene-Targeted Cancer Fix Could Be a Breakthrough
3. Survival in metastatic breast cancer patients is improving: targeted therapies have contributed
4. Targeted agent blocked growth of deadly brain cancer in preclinical studies
5. Kaiser Permanente Southern California to Offer FitOrbit Online Personal Training to Targeted Patients
6. New targeted therapy effective in treating advanced prostate cancer
7. Gene-Targeted Therapy Might Help Prevent Paralysis
8. Site Steering Launches Keyword Targeted Small Business Internet Video Advertising Program That Achieves First Page Search Results Within Days
9. Drug in new class of targeted therapies shows early promise against blood-related cancers
10. Women Smokers Targeted on World No Tobacco Day
11. Targeted immunotherapy shows promise for metastatic breast, pancreatic cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and ... essential oils, announced the company had a successful visit to the 2017 ECRM Diet, ... gives companies that work in the nutritional, sports and health industries a chance to ...
(Date:1/20/2017)... FL (PRWEB) , ... January 20, 2017 , ... International ... of nutritional and bodybuilding supplements, announced it attended the January ECRM trade show in ... bodybuilder and nutritional scientist who was determined to create a line of products that ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and earnest tale ... each of his children. “The Angel” is the creation of published author, Marjorie Lund-Fontaine, ... City, and impassioned writer. , When asked of her new book, Marjorie says, “‘The ...
(Date:1/20/2017)... ... ... to Christmas:” a beautiful and enchanting tale that teaches children the true meaning of Christmas. ... in Oklahoma City, and a devoted woman of faith. , “Becoming a parent changes ... back of my mind for years, but actually doing it might have been a while ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... E-learning system for Clinical and Regulatory education for Physicians, Physician Advisors, Case ... successful education methodology of Disease Specific Documentation Improvement. , The Aerolib Learning ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... LONDON , January 19, 2017 ... Grothey ; European Oncology & Haematology, 2016;12(Suppl 2):3-8; ... ... http://photos.prnewswire.com/prnh/20151014/276718LOGO) Published recently in ... the peer-reviewed journal from touchONCOLOGY, an article by ...
(Date:1/19/2017)... , Jan. 19, 2017 ViewRay, Inc. ... a federal institution supporting research in Germany ... and patient treatments at the University Clinic Heidelberg as ... The MRIdian Linac program will be headed by ... also heads radiation oncology at the German Cancer Research ...
(Date:1/19/2017)... Calif. , Jan. 19, 2017   Science ... is excited to announce that the first five ... Biology  (RP:CB) have been published in eLife today. ... project represents the first practical evaluation of reproducibility ... in reproducible studies. Unlike other assessments of reproducibility, ...
Breaking Medicine Technology: